US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 43.800
  • -1.150-2.56%
Close Nov 29 13:00 ET
  • 43.800
  • 0.0000.00%
Post 17:01 ET
2.61BMarket Cap15.99P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
4.68M
4.17M
254.95M
125.73%60M
60M
0
0
0
-2.84%26.58M
0
Operating revenue
--4.68M
--4.17M
--254.95M
125.73%60M
--60M
--0
--0
--0
-2.84%26.58M
--0
Cost of revenue
Gross profit
Operating expense
20.36%46.13M
1.43%42.96M
35.04%48.64M
-2.72%153.65M
1.19%36.95M
18.65%38.33M
0.12%42.35M
-23.09%36.02M
3.10%157.95M
-19.98%36.52M
Selling and administrative expenses
32.58%10.16M
2.92%9.44M
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
16.70%31.74M
-8.65%6.63M
-General and administrative expense
32.58%10.16M
2.92%9.44M
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
16.70%31.74M
-8.65%6.63M
Research and development costs
17.30%35.97M
1.02%33.52M
23.04%33.73M
-4.80%120.16M
-3.30%28.9M
20.71%30.66M
-4.13%33.18M
-24.51%27.42M
0.17%126.22M
-22.12%29.88M
Operating profit
-8.16%-41.45M
8.41%-38.79M
672.75%206.31M
28.71%-93.65M
163.12%23.05M
-18.65%-38.33M
-2.20%-42.35M
-70.63%-36.02M
-4.39%-131.37M
1.35%-36.52M
Net non-operating interest income expense
80.67%7.68M
89.22%7.4M
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
816.48%4.06M
1,745.08%2.25M
Non-operating interest income
80.67%7.68M
89.22%7.4M
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
816.48%4.06M
1,745.08%2.25M
Other net income (expense)
554.84%141K
610.53%97K
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
46.31%-80K
646.15%71K
Other non- operating income (expenses)
554.84%141K
610.53%97K
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
46.31%-80K
646.15%71K
Income before tax
1.39%-33.63M
18.64%-31.29M
724.66%210.67M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Income tax
-420K
-676K
3.33M
0
0
0
Net income
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Net income continuous Operations
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Minority interest income
Net income attributable to the parent company
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Basic earnings per share
6.90%-0.54
26.47%-0.5
608.96%3.41
46.54%-1.39
165.22%0.45
9.38%-0.58
19.05%-0.68
-55.81%-0.67
4.06%-2.6
10.39%-0.69
Diluted earnings per share
6.90%-0.54
26.47%-0.5
586.57%3.26
46.54%-1.39
163.77%0.44
9.38%-0.58
19.05%-0.68
-55.81%-0.67
4.06%-2.6
10.39%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 4.68M4.17M254.95M125.73%60M60M000-2.84%26.58M0
Operating revenue --4.68M--4.17M--254.95M125.73%60M--60M--0--0--0-2.84%26.58M--0
Cost of revenue
Gross profit
Operating expense 20.36%46.13M1.43%42.96M35.04%48.64M-2.72%153.65M1.19%36.95M18.65%38.33M0.12%42.35M-23.09%36.02M3.10%157.95M-19.98%36.52M
Selling and administrative expenses 32.58%10.16M2.92%9.44M73.27%14.91M5.52%33.49M21.41%8.05M11.03%7.66M19.26%9.17M-18.16%8.61M16.70%31.74M-8.65%6.63M
-General and administrative expense 32.58%10.16M2.92%9.44M73.27%14.91M5.52%33.49M21.41%8.05M11.03%7.66M19.26%9.17M-18.16%8.61M16.70%31.74M-8.65%6.63M
Research and development costs 17.30%35.97M1.02%33.52M23.04%33.73M-4.80%120.16M-3.30%28.9M20.71%30.66M-4.13%33.18M-24.51%27.42M0.17%126.22M-22.12%29.88M
Operating profit -8.16%-41.45M8.41%-38.79M672.75%206.31M28.71%-93.65M163.12%23.05M-18.65%-38.33M-2.20%-42.35M-70.63%-36.02M-4.39%-131.37M1.35%-36.52M
Net non-operating interest income expense 80.67%7.68M89.22%7.4M75.67%4.38M266.95%14.9M88.45%4.24M267.50%4.25M708.47%3.91M1,382.74%2.49M816.48%4.06M1,745.08%2.25M
Non-operating interest income 80.67%7.68M89.22%7.4M75.67%4.38M266.95%14.9M88.45%4.24M267.50%4.25M708.47%3.91M1,382.74%2.49M816.48%4.06M1,745.08%2.25M
Other net income (expense) 554.84%141K610.53%97K90.26%-19K-151.25%-201K-38.03%44K63.95%-31K75.64%-19K-1,600.00%-195K46.31%-80K646.15%71K
Other non- operating income (expenses) 554.84%141K610.53%97K90.26%-19K-151.25%-201K-38.03%44K63.95%-31K75.64%-19K-1,600.00%-195K46.31%-80K646.15%71K
Income before tax 1.39%-33.63M18.64%-31.29M724.66%210.67M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M
Income tax -420K-676K3.33M000
Net income 2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M
Net income continuous Operations 2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M
Minority interest income
Net income attributable to the parent company 2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M
Basic earnings per share 6.90%-0.5426.47%-0.5608.96%3.4146.54%-1.39165.22%0.459.38%-0.5819.05%-0.68-55.81%-0.674.06%-2.610.39%-0.69
Diluted earnings per share 6.90%-0.5426.47%-0.5586.57%3.2646.54%-1.39163.77%0.449.38%-0.5819.05%-0.68-55.81%-0.674.06%-2.610.39%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data